Who owns CNS PHARMACEUTICALS INC?
- Ticker: CNSP
- CUSIP Number: 18978h201
Tip: Access positions for across all investors
Analyze quarterly positions in Cns Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cns Pharmaceuticals stock
Who bought or sold CNS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Smith Anglin Financial | 90k | $33k | 81% | Mar 2024 |
|
| Vanguard Group | 58k | $74k | 146% | Dec 2023 |
|
| Virtu Financial | 13k | $17k | 100% | Dec 2023 |
|
| Wells Fargo & Company | 207.00 | $265.208400 | -59% | Dec 2023 |
|
| Global Retirement Partners | 53.00 | $19.000500 | 0% | Mar 2024 |
|
| Bank of America Corporation | 1.00 | $1.000000 | -86% | Dec 2023 |
|
| Plante Moran Financial Advisors | 1.00 | $1.000000 | 0% | Dec 2023 |
|
Who sold out of Cns Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Sep 2023 | 55.00 | $63.002500 |